Special Issue "Catechins and Human Health: Current State of the Science"
Deadline for manuscript submissions: closed (31 August 2016)
Dr. Joshua D. Lambert
Department of Food Science, Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, PA 16802, USA
Website | E-Mail
Interests: cancer prevention by dietary components; obesity and inflammation prevention by dietary components; food toxicology; bioavailability and biotransformation of dietary components; natural products chemistry
Catechins are polyphenolic phytochemicals that are widely distributed in food and medicinal plants. A growing number of studies have linked intake of catechin-rich foods with prevention of chronic disease in human populations, and laboratory studies have demonstrated the potential preventive activity of catechins in laboratory models of cancer, cardiovascular disease, neurodegenerative disease, and metabolic syndrome. Although a number of potential mechanisms of action have been proposed to account for these effects, many questions remain. Understanding of the key mechanisms of action are complicated by the fact that catechins are extensively biotransformed both by mammalian enzyme systems, as well as the gut microbiota.
This Special Issue is devoted to summarizing the current state of the science on catechins and human health. Topics will include laboratory and human studies on the prevention of cancer, cardiovascular disease, and metabolic syndrome by catechins. Special focus will be given to mechanistically-informative in vivo studies, controlled human intervention studies, and human observational studies. The Special Issue will also deal with emerging topics, including the impact of catechins on the gut microbiota.
Dr. Joshua D. Lambert
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cancer prevention
- cardiovascular disease
- neurodegenerative disease
- metabolic syndrome
- gut microbiota